Skip to main content
. 2012 Dec 20;18(1):104–111. doi: 10.1634/theoncologist.2012-0235

Table 2.

Correlation between development parameters and approval time

graphic file with name onc00113-1221-t02.jpg

For each parameter, the approval time quartiles are presented both for the group of approvals where the parameter was not present (no) and the group of approvals where the parameter was present (yes). Molecular specification: n = 83 for no and n = 46 for yes; accelerated approval: n = 90 for no and n = 39 for yes; randomized controlled trial: n = 44 for no and n = 85 for yes.